Similar articles

• Continuous ECG monitoring of children with cancer receiving domperidone.

  Ratcliffe JM, Nobbs J, Campbell RW, Hunter AS, Pritchard-Jones K, Craft AW. Ratcliffe JM, et al. Pediatr Hematol Oncol. 1986;3(4):343-6. doi: 10.3109/08880018609031236. Pediatr Hematol Oncol. 1986. PMID: 3153247
• Extrapyramidal disorders with domperidone.

  [No authors listed] [No authors listed] Prescrire Int. 2017 Feb;26(179):44. Prescrire Int. 2017. PMID: 30726631 No abstract available.
• Increase in mammographic breast density associated with the use of domperidone.

  Harvey JA, Cowan JH 3rd, LoRusso AP. Harvey JA, et al. Breast J. 2004 May-Jun;10(3):256-8. doi: 10.1111/j.1075-122X.2004.21441.x. Breast J. 2004. PMID: 15125756 No abstract available.
• [Domperidone and the risk of sudden cardiac death].

  van Roeden SE, Belle-van Meerkerk G, van Tuyl SA, van de Ree MA, Muller AF. van Roeden SE, et al. Ned Tijdschr Geneeskd. 2013;157(45):A6770. Ned Tijdschr Geneeskd. 2013. PMID: 24191928 Review. Dutch.
• Domperidone: limited benefits with significant risk for sudden cardiac death.

  Hondeghem LM. Hondeghem LM. J Cardiovasc Pharmacol. 2013 Mar;61(3):218-25. doi: 10.1097/FJC.0b013e31827afd0d. J Cardiovasc Pharmacol. 2013. PMID: 23188128 Review.